Otitis
14
3
3
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
90.0%
+3.5% vs benchmark
14%
2 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Complicated Infections in Otorhinolaryngology
RSV Burden in Outpatient and Hospital Settings
Pediatric and Ambulatory Research in Infectious Diseases
Postoperative Controls of Ventilation Tubes in Children - by General Practitioner or Otolaryngologist?
Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy
Eustachian Tube Testing in a Pressure Chamber -- Validation Study
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation
Community Pediatric Acceptability Study (CPAS)
Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
Dexmedetomidine vs Fentanyl for BMT
Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.